Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perampanel Extension in Parkinson's Disease
NCT00505622Phase 3Terminated
- Sponsor
- Eisai Co., Ltd.
- Start
- Jul 2007
- Primary completion
- Apr 2008
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of perampanel in Parkinson's disease (PD), sponsored by Eisai Co., Ltd.. Started Jul 2007; status: terminated.
02
Drugs
perampanel
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00505622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00505622.